{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,5]],"date-time":"2023-09-05T14:34:23Z","timestamp":1693924463680},"reference-count":50,"publisher":"Hindawi Limited","issue":"6","license":[{"start":{"date-parts":[[2016,8,31]],"date-time":"2016-08-31T00:00:00Z","timestamp":1472601600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2016,8,31]],"date-time":"2016-08-31T00:00:00Z","timestamp":1472601600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Clin Pharm Ther"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1111\/jcpt.12443","type":"journal-article","created":{"date-parts":[[2016,8,31]],"date-time":"2016-08-31T16:56:59Z","timestamp":1472662619000},"page":"587-591","source":"Crossref","is-referenced-by-count":4,"title":["The pharmacotherapy of cirrhosis: concerns and proposed investigations and solutions"],"prefix":"10.1155","volume":"41","author":[{"given":"M. B.","family":"Hilscher","sequence":"first","affiliation":[{"name":"Department of Gastroenterology and Hepatology; Mayo Clinic; Rochester MN USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L. J.","family":"Odell","sequence":"additional","affiliation":[{"name":"Department of Pharmacy; Mayo Clinic; Rochester MN USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L. J.","family":"Myhre","sequence":"additional","affiliation":[{"name":"Department of Pharmacy; Mayo Clinic; Rochester MN USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Prokop","sequence":"additional","affiliation":[{"name":"Department of Education Administration; Mayo Clinic; Rochester MN USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Talwalkar","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology; Mayo Clinic; Rochester MN USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"98","published-online":{"date-parts":[[2016,8,31]]},"reference":[{"key":"10.1111\/jcpt.12443-BIB0001|jcpt12443-cit-0001","doi-asserted-by":"crossref","first-page":"529","DOI":"10.2165\/00002018-200528060-00005","article-title":"Dose adjustment in patients with liver disease","volume":"28","author":"Delco","year":"2005","journal-title":"Drug Saf"},{"key":"10.1111\/jcpt.12443-BIB0002|jcpt12443-cit-0002","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s00228-011-1105-5","article-title":"Potential drug-drug interactions and adverse drug reactions in patients with liver cirrhosis","volume":"68","author":"Franz","year":"2012","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1111\/jcpt.12443-BIB0003|jcpt12443-cit-0003","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1111\/apt.12324","article-title":"Review article: prescribing medications in patients with cirrhosis - a practical guide","volume":"37","author":"Lewis","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1111\/jcpt.12443-BIB0004|jcpt12443-cit-0004","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1023\/A:1008656930082","article-title":"Effect of hepatic insufficiency on pharmacokinetics and drug dosing","volume":"20","author":"Verbeeck","year":"1998","journal-title":"Pharm World Sci"},{"key":"10.1111\/jcpt.12443-BIB0005|jcpt12443-cit-0005","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1007\/s00228-008-0553-z","article-title":"Pharmacokinetics and dosage adjustment in patients with hepatic dysfunction","volume":"64","author":"Verbeeck","year":"2008","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1111\/jcpt.12443-BIB0006|jcpt12443-cit-0006","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2165\/00002018-199717010-00004","article-title":"Drug administration in chronic liver disease","volume":"17","author":"Westphal","year":"1997","journal-title":"Drug Saf"},{"key":"10.1111\/jcpt.12443-BIB0007|jcpt12443-cit-0007","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40262-012-0018-5","article-title":"The clinical relevance of plasma protein binding changes","volume":"52","author":"Roberts","year":"2013","journal-title":"Clin Pharmacokinet"},{"key":"10.1111\/jcpt.12443-BIB0008|jcpt12443-cit-0008","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/01.mjt.0000140216.40700.95","article-title":"The therapeutic use of acetaminophen in patients with liver disease","volume":"12","author":"Benson","year":"2005","journal-title":"Am J Ther"},{"key":"10.1111\/jcpt.12443-BIB0009|jcpt12443-cit-0009","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1056\/NEJM199102073240605","article-title":"The nature of adverse events in hospitalized patients. Results of the Harvard Medical Practice Study II","volume":"324","author":"Leape","year":"1991","journal-title":"New Engl J Med"},{"key":"10.1111\/jcpt.12443-BIB0010|jcpt12443-cit-0010","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1001\/jama.279.15.1200","article-title":"Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies","volume":"279","author":"Lazarou","year":"1998","journal-title":"JAMA"},{"key":"10.1111\/jcpt.12443-BIB0011|jcpt12443-cit-0011","unstructured":"Organization WH The Importance of Pharmacovigilance: Safety Monitoring of medicinal products http:\/\/apps.who.int\/iris\/bitstream\/10665\/42493\/1\/a75646.pdf"},{"key":"10.1111\/jcpt.12443-BIB0012|jcpt12443-cit-0012","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1001\/jama.279.15.1216","article-title":"Drugs and adverse drug reactions: how worried should we be?","volume":"279","author":"Bates","year":"1998","journal-title":"JAMA"},{"key":"10.1111\/jcpt.12443-BIB0013|jcpt12443-cit-0013","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S0140-6736(98)24009-8","article-title":"Increase in US medication-error deaths between 1983 and 1993","volume":"351","author":"Phillips","year":"1998","journal-title":"Lancet"},{"key":"10.1111\/jcpt.12443-BIB0014|jcpt12443-cit-0014","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1001\/archinte.1991.00400090107019","article-title":"Explicit criteria for determining inappropriate medication use in nursing home residents. UCLA Division of Geriatric Medicine","volume":"151","author":"Beers","year":"1991","journal-title":"Arch Intern Med"},{"key":"10.1111\/jcpt.12443-BIB0015|jcpt12443-cit-0015","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/jep.12319","article-title":"A comparison of the Beers and STOPP criteria for identifying the use of potentially inappropriate medications among elderly patients in primary care","volume":"21","author":"Oliveira","year":"2015","journal-title":"J Eval Clin Pract"},{"key":"10.1111\/jcpt.12443-BIB0016|jcpt12443-cit-0016","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1038\/ki.2011.322","article-title":"Drug dosing consideration in patients with acute and chronic kidney disease-a clinical update from Kidney Disease: Improving Global Outcomes (KDIGO)","volume":"80","author":"Matzke","year":"2011","journal-title":"Kidney Int"},{"key":"10.1111\/jcpt.12443-BIB0017|jcpt12443-cit-0017","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/j.1365-2125.2012.04220.x","article-title":"Interventions to reduce medication errors in adult intensive care: a systematic review","volume":"74","author":"Manias","year":"2012","journal-title":"Br J Clin Pharmacol"},{"key":"10.1111\/jcpt.12443-BIB0018|jcpt12443-cit-0018","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5414\/CP201705","article-title":"Use of contraindicated drugs in patients with chronic liver disease: a therapeutic dilemma","volume":"51","author":"Sistanizad","year":"2013","journal-title":"Int J Clin Pharmacol Ther"},{"key":"10.1111\/jcpt.12443-BIB0019|jcpt12443-cit-0019","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1111\/j.1365-2036.2008.03822.x","article-title":"Review article: The use of potentially hepatotoxic drugs in patients with liver disease","volume":"28","author":"Gupta","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1111\/jcpt.12443-BIB0020|jcpt12443-cit-0020","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1517\/14740338.1.2.159","article-title":"The rational use of potentially hepatotoxic medications in patients with underlying liver disease","volume":"1","author":"Lewis","year":"2002","journal-title":"Exp Opin Drug Saf"},{"key":"10.1111\/jcpt.12443-BIB0021|jcpt12443-cit-0021","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s00228-003-0586-2","article-title":"Drug use for non-hepatic associated conditions in patients with liver cirrhosis","volume":"59","author":"Lucena","year":"2003","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1111\/jcpt.12443-BIB0022|jcpt12443-cit-0022","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1177\/00912700022008649","article-title":"Cardiovascular drug therapy in patients with hepatic diseases and patients with congestive heart failure","volume":"40","author":"Sokol","year":"2000","journal-title":"J Clin Pharmacol"},{"key":"10.1111\/jcpt.12443-BIB0023|jcpt12443-cit-0023","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s00228-002-0474-1","article-title":"Multicenter hospital study on prescribing patterns for prophylaxis and treatment of complications of cirrhosis","volume":"58","author":"Lucena","year":"2002","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1111\/jcpt.12443-BIB0024|jcpt12443-cit-0024","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1111\/j.1530-0277.1986.tb05167.x","article-title":"Vitamin K deficiency in chronic alcoholic males","volume":"10","author":"Iber","year":"1986","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1111\/jcpt.12443-BIB0025|jcpt12443-cit-0025","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/MBC.0b013e32835975ed","article-title":"The coagulopathy of liver disease: does vitamin K help?","volume":"24","author":"Saja","year":"2013","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1111\/jcpt.12443-BIB0026|jcpt12443-cit-0026","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/nrgastro.2014.121","article-title":"Procoagulant therapeutics in liver disease: a critique and clinical rationale","volume":"11","author":"Shah","year":"2014","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1111\/jcpt.12443-BIB0027|jcpt12443-cit-0027","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.jhep.2004.11.030","article-title":"Pharmacokinetics and efficacy of oral versus intravenous mixed-micellar phylloquinone (vitamin K1) in severe acute liver disease","volume":"42","author":"Pereira","year":"2005","journal-title":"J Hepatol"},{"key":"10.1111\/jcpt.12443-BIB0028|jcpt12443-cit-0028","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1007\/s00228-013-1502-z","article-title":"Dose adjustment in patients with liver cirrhosis: impact on adverse drug reactions and hospitalizations","volume":"69","author":"Franz","year":"2013","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1111\/jcpt.12443-BIB0029|jcpt12443-cit-0029","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/S0002-9149(02)02355-X","article-title":"The liver and lovastatin","volume":"89","author":"Tolman","year":"2002","journal-title":"Am J Cardiol"},{"key":"10.1111\/jcpt.12443-BIB0030|jcpt12443-cit-0030","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1053\/j.gastro.2004.02.015","article-title":"Patients with elevated liver enzymes are not at higher risk for statin hepatotoxicity","volume":"126","author":"Chalasani","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1111\/jcpt.12443-BIB0031|jcpt12443-cit-0031","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1097\/00000441-200502000-00002","article-title":"Patients with elevated baseline liver enzymes do not have higher frequency of hepatotoxicity from lovastatin than those with normal baseline liver enzymes","volume":"329","author":"Vuppalanchi","year":"2005","journal-title":"Am J Med Sci"},{"key":"10.1111\/jcpt.12443-BIB0032|jcpt12443-cit-0032","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1002\/hep.21248","article-title":"Statins and hepatic steatosis: perspectives from the Dallas Heart Study","volume":"44","author":"Browning","year":"2006","journal-title":"Hepatology"},{"key":"10.1111\/jcpt.12443-BIB0033|jcpt12443-cit-0033","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/MAJ.0b013e3181e15da8","article-title":"Hepatotoxicity fears contribute to underutilization of statin medications by primary care physicians","volume":"340","author":"Rzouq","year":"2010","journal-title":"Am J Med Sci"},{"key":"10.1111\/jcpt.12443-BIB0034|jcpt12443-cit-0034","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1001\/archinternmed.2012.2246","article-title":"Hospital-based medication reconciliation practices: a systematic review","volume":"172","author":"Mueller","year":"2012","journal-title":"Arch Intern Med"},{"key":"10.1111\/jcpt.12443-BIB0035|jcpt12443-cit-0035","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1001\/archinte.166.5.565","article-title":"Role of pharmacist counseling in preventing adverse drug events after hospitalization","volume":"166","author":"Schnipper","year":"2006","journal-title":"Arch Intern Med"},{"key":"10.1111\/jcpt.12443-BIB0036|jcpt12443-cit-0036","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1200\/JCO.2014.58.7550","article-title":"Evaluation of a pharmacist-led medication assessment used to identify prevalence of and associations with polypharmacy and potentially inappropriate medication use among ambulatory senior adults with cancer","volume":"33","author":"Nightingale","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1111\/jcpt.12443-BIB0037|jcpt12443-cit-0037","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1097\/01.CCM.0000201886.84135.CB","article-title":"Minimizing errors of omission: behavioural reenforcement of heparin to avert venous emboli: the BEHAVE study","volume":"34","author":"McMullin","year":"2006","journal-title":"Crit Care Med"},{"key":"10.1111\/jcpt.12443-BIB0038|jcpt12443-cit-0038","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1097\/01.CCM.0000114835.97789.AB","article-title":"Format of medical order sheet improves security of antibiotics prescription: the experience of an intensive care unit","volume":"32","author":"Wasserfallen","year":"2004","journal-title":"Crit Care Med"},{"key":"10.1111\/jcpt.12443-BIB0039|jcpt12443-cit-0039","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1001\/archinte.1997.00440350031003","article-title":"Explicit criteria for determining potentially inappropriate medication use by the elderly. An update","volume":"157","author":"Beers","year":"1997","journal-title":"Arch Intern Med"},{"key":"10.1111\/jcpt.12443-BIB0040|jcpt12443-cit-0040","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.1001\/archinte.163.22.2716","article-title":"Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts","volume":"163","author":"Fick","year":"2003","journal-title":"Arch Intern Med"},{"key":"10.1111\/jcpt.12443-BIB0041|jcpt12443-cit-0041","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1111\/j.1532-5415.2012.03923.x","article-title":"American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in older adults","volume":"60","author":"American Geriatrics Society Beers Criteria Update Expert P","year":"2012","journal-title":"J Am Geriatr Soc"},{"key":"10.1111\/jcpt.12443-BIB0042|jcpt12443-cit-0042","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1111\/jgs.13702","article-title":"American Geriatrics Society 2015 updated beers criteria for potentially inappropriate medication use in older adults","volume":"63","author":"By the American Geriatrics Society Beers Criteria Update Expert P","year":"2015","journal-title":"J Am Geriatr Soc"},{"key":"10.1111\/jcpt.12443-BIB0043|jcpt12443-cit-0043","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1093\/ageing\/afr012","article-title":"Potentially inappropriate medication use among older adults in the USA in 2007","volume":"40","author":"Zhang","year":"2011","journal-title":"Age Ageing"},{"key":"10.1111\/jcpt.12443-BIB0044|jcpt12443-cit-0044","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1001\/archinte.165.1.68","article-title":"Hospitalization and death associated with potentially inappropriate medication prescriptions among elderly nursing home residents","volume":"165","author":"Lau","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1111\/jcpt.12443-BIB0045|jcpt12443-cit-0045","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1592\/phco.29.12.1433","article-title":"Reduced drug use and hospitalization rates in patients undergoing hemodialysis who received pharmaceutical care: a 2-year, randomized, controlled study","volume":"29","author":"Pai","year":"2009","journal-title":"Pharmacotherapy"},{"key":"10.1111\/jcpt.12443-BIB0046|jcpt12443-cit-0046","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1177\/0145721715587563","article-title":"Assessing the effectiveness of pharmacist-directed medication therapy management in improving diabetes outcomes in patients with poorly controlled diabetes","volume":"41","author":"Skinner","year":"2015","journal-title":"Diabetes Educ"},{"key":"10.1111\/jcpt.12443-BIB0047|jcpt12443-cit-0047","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1345\/aph.1E438","article-title":"Caring for poorly controlled diabetes mellitus: a randomized pharmacist intervention","volume":"39","author":"Odegard","year":"2005","journal-title":"Ann Pharmacother"},{"key":"10.1111\/jcpt.12443-BIB0048|jcpt12443-cit-0048","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.pcd.2007.12.001","article-title":"Effects of the pharmacist's input on glycaemic control and cardiovascular risks in Muslim diabetes","volume":"2","author":"Phumipamorn","year":"2008","journal-title":"Prim Care Diabetes"},{"key":"10.1111\/jcpt.12443-BIB0049|jcpt12443-cit-0049","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1177\/1060028015599637","article-title":"Impact of a multidisciplinary heart failure post-hospitalization program on heart failure readmission rates","volume":"49","author":"Jackevicius","year":"2015","journal-title":"Ann Pharmacother"},{"key":"10.1111\/jcpt.12443-BIB0050|jcpt12443-cit-0050","doi-asserted-by":"crossref","first-page":"714","DOI":"10.7326\/0003-4819-146-10-200705150-00005","article-title":"Pharmacist intervention to improve medication adherence in heart failure: a randomized trial","volume":"146","author":"Murray","year":"2007","journal-title":"Ann Intern Med"}],"container-title":["Journal of Clinical Pharmacy and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjcpt.12443","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjcpt.12443","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/jcpt.12443\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T18:02:05Z","timestamp":1671818525000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jcpt.12443"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,31]]},"references-count":50,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,12]]}},"URL":"https:\/\/doi.org\/10.1111\/jcpt.12443","archive":["Portico"],"relation":{},"ISSN":["0269-4727"],"issn-type":[{"value":"0269-4727","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8,31]]}}}